LI
LifeCyte Innovations, Inc.
SEC filingPharmaceuticals · Greensboro, GA
Amount raised$1Msold at filing
Total offering$5M$4M still open
Investors in the raise3count reported to the SEC
FiledAug 20, 2026first sale Aug 12, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Kenneth BrownExecutive Officer, Director
Michael MoorheadExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.